KONTAN.CO.ID - JAKARTA. Pharmaceutical issuer PT Kalbe Farma Tbk (KLBF) is optimistic about achieving double-digit profit growth by 2024. KLBF President Director Vidjongtius said that this year is a year of recovery for Kalbe Farma, after previously recording a decline in the third quarter. KLBF's net profit reached IDR 2.06 trillion in the first nine months of 2023. Kalbe's net profit fell 16.9% compared to the same period last year due to challenging market conditions in the post-pandemic transition period.
Kalbe Farma (KLBF) Optimistic About Double-Digit Profit Growth in 2024
KONTAN.CO.ID - JAKARTA. Pharmaceutical issuer PT Kalbe Farma Tbk (KLBF) is optimistic about achieving double-digit profit growth by 2024. KLBF President Director Vidjongtius said that this year is a year of recovery for Kalbe Farma, after previously recording a decline in the third quarter. KLBF's net profit reached IDR 2.06 trillion in the first nine months of 2023. Kalbe's net profit fell 16.9% compared to the same period last year due to challenging market conditions in the post-pandemic transition period.